Eagle Bay Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-76
| Closed | -$125 | – | 409 |
|
|
2024
Q4 | $125 | Hold |
76
| – | – | ﹤0.01% | 985 |
|
|
2024
Q3 | $266 | Hold |
76
| – | – | ﹤0.01% | 1326 |
|
|
2024
Q2 | $249 | Hold |
76
| – | – | ﹤0.01% | 967 |
|
|
2024
Q1 | $558 | Hold |
76
| – | – | ﹤0.01% | 941 |
|
|
2023
Q4 | $284 | Hold |
76
| – | – | ﹤0.01% | 810 |
|
|
2023
Q3 | $161 | Hold |
76
| – | – | ﹤0.01% | 833 |
|
|
2023
Q2 | $362 | Hold |
76
| – | – | ﹤0.01% | 816 |
|
|
2023
Q1 | $433 | Hold |
76
| – | – | ﹤0.01% | 873 |
|
|
2022
Q4 | $767 | Hold |
76
| – | – | ﹤0.01% | 833 |
|
|
2022
Q3 | $2K | Hold |
76
| – | – | ﹤0.01% | 754 |
|
|
2022
Q2 | $1.88K | Buy |
+76
| New | +$1.88K | ﹤0.01% | 793 |
|
|
2022
Q1 | – | Sell |
-76
| Closed | -$4K | – | 529 |
|
|
2021
Q4 | $4K | Hold |
76
| – | – | ﹤0.01% | 800 |
|
|
2021
Q3 | $5K | Buy |
+76
| New | +$5K | ﹤0.01% | 791 |
|